S1689 Intravenous and Subcutaneous Guselkumab Induction Therapy Are Both Efficacious in Crohn’s Disease Patients With High Baseline Disease Severity: Results at Week 12 From the Phase 3 GALAXI and GRAVITI Studies
Year: 2025
Type: conference-abstract
Authors: Bruce E. Sands, Tadakazu Hisamatsu, Anita Afzali, Nat A. Terry, Mobolaji Olurinde, Rian Van Rampelbergh, Jacqueline Yee, Wilbert van Duijnhoven, Ailsa Hart, Silvio Danese, Remo Panaccione
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7110992863
Cites:
Cited by:
Related to: